Health systems

HSS sessions at XVII International Aids Conference

Essential Medicines and Pharmaceutical Policies

Essential Medicines for HIV AIDS - An Update

HSS sessions venue

• Type: Satellite Discussion
• Session Room 5, Exhibition Level, Level 1
• Date: Wednesday, 6 August 2008
• Time: 18:30 - 20:30

Essential Medicines for HIV AIDS - An Update

An update on the World Health Organization's and its partners' activities in the field of promoting access, quality and rational use of essential medicines for HIV & AIDS. Particular emphasis will be on issues of selection, safety, quality and pricing. There will be an opportunity for questions and an open discussion on medicine-related topics.

World Health Organization, Clinton Foundation HIV/AIDS Initiative, The Global Fund for AIDS, TB and Malaria, Supply Chain Management System (SCMS), UNICEF, and UNITAID

Selection and Safety

Health Systems Strengthening, Primary Health Care & medicines as a human right
Hans Hogerzeil - Director, Essential Medicines and Pharmaceutical Policies, WHO
Treating all children with HIV - should we treat infants with protease inhibitors?
Siobhan Crowley - Medical Officer, Antiretroviral treatment and HIV Care, WHO
Panel discussion also with:
Helene Moller - Medicine Access and Rational Use, WHO
James Fitzgerald - Pan-American Health Organization, WHO
Atieno Ojoo - Supply Division, UNICEF

Quality and Pricing

Supporting efforts to increase access to quality medicines for children Atieno Ojoo - Supply Division, UNICEF
Ensuring quality of medicines procured with global funds Joelle Daviaud - Procurement Team, The Global Fund for AIDS, TB and Malaria
Investing in the quality of medicines Jorge Berumudez - Executive Secretary, UNITAID
Price trends of HIV and AIDS medicines - finding and using data Joseph Perriens - Coordinator, Systems Strengthening and HIV AIDS, WHO
Panel discussion also with:
David Jamieson - Deputy Director for Country programs and Partnerships at the PEPFAR-fund Supply Chain Management System (SCMS) Dai Ellis - Director Drug Access Team, Clinton Foundation HIV/AIDS Initiative